Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and …
Over the last 12 months, insiders at Nephros, Inc. have bought $140,356 and sold $0 worth of Nephros, Inc. stock.
On average, over the past 5 years, insiders at Nephros, Inc. have bought $86,761 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Banks Robert R. Jr. (President and CEO) — $112,050. Amron Arthur H (director) — $56,612.
The last purchase of 3,000 shares for transaction amount of $6,735 was made by Amron Arthur H (director) on 2024‑05‑30.
2024-05-30 | director | 3,000 0.029% | $2.24 | $6,735 | -17.73% | |||
2024-05-28 | director | 2,000 0.0192% | $2.22 | $4,441 | -17.12% | |||
2024-05-16 | President and CEO | 50,000 0.4723% | $2.24 | $112,050 | -19.38% | |||
2024-03-12 | director | 7,000 0.0704% | $2.45 | $17,130 | -12.50% | |||
2023-12-07 | President and CEO | 18,000 0.1818% | $2.20 | $39,647 | +2.83% | |||
2023-08-15 | President and CEO | 1,901 0.0203% | $1.69 | $3,207 | +45.03% | |||
2023-08-14 | President and CEO | 99 0.0009% | $1.50 | $149 | +43.14% | |||
2021-08-20 | Chief Marketing Officer | 1,000 0.0101% | $7.92 | $7,920 | -39.82% | |||
2021-08-18 | President & CEO | 2,500 0.0255% | $7.77 | $19,433 | -37.63% | |||
2021-08-18 | director | 5,000 0.05% | $7.64 | $38,200 | -37.63% | |||
2021-08-17 | President & CEO | 2,500 0.0249% | $7.67 | $19,172 | -37.91% | |||
2020-11-19 | President & CEO | 1,000 0.011% | $5.87 | $5,867 | +36.52% | |||
2020-11-18 | director | 1,500 0.0161% | $5.83 | $8,749 | +33.78% | |||
2020-08-19 | COO/CFO | 950 0.0105% | $7.40 | $7,030 | +4.44% | |||
2020-05-28 | CFO/COO | 1,000 0.0099% | $6.96 | $6,960 | -2.31% | |||
2020-03-12 | President and CEO | 2,500 0.0298% | $6.65 | $16,625 | +15.79% | |||
2020-03-12 | CFO/COO | 1,000 0.012% | $6.70 | $6,700 | +15.79% | |||
2020-03-05 | President and CEO | 2,500 0.0298% | $8.44 | $21,109 | -9.03% | |||
2020-03-05 | CFO/COO | 700 0.0084% | $8.46 | $5,920 | -9.03% | |||
2019-11-25 | director | 1,000 0.0132% | $8.17 | $8,170 | -5.37% |
Amron Arthur H | director | 103463 0.9812% | $1.49 | 3 | 0 | |
Banks Robert R. Jr. | President and CEO | 70000 0.6639% | $1.49 | 4 | 0 | |
Lambda Investors LLC | 10 percent owner | 6721676 63.7476% | $1.49 | 1 | 0 | |
Enso Capital Management LLC | 10 percent owner | 3407616 32.3174% | $1.49 | 3 | 31 | |
ROSENBERG MATTHEW | director | 789695 7.4894% | $1.49 | 1 | 0 |